PremiumThe FlyLyell Immunopharma reports Q4 net loss $45.9M vs. net loss $44M last year LYEL Earnings this Week: How Will it Perform? Pacira appoints Teehan as CCO, Corbett as CBO PremiumPre-EarningsIs LYEL a Buy, Before Earnings? Buy/Sell: Wall Street’s top 10 stock calls this week Lyell Immunopharma’s Strategic Moves and Leadership Expansion PremiumThe FlyCaribou Biosciences Ltp appoims Albertso as CMO Lyell Immunopharma reports Q2 revenue $40.3M vs.$47M last year Dynatrace initiated, U.S. Bancorp downgraded: Wall Street’s top analyst calls 
